Latest News Archive

Please select Category, Year, and then Month to display items

Human Rights Week webinar: Africa, human rights, and transformation

15 March 2021

What do Africa, human rights, and transformation have to do with one another? Are human rights instruments for transformation in Africa, neo-colonial impositions, or the last refuge of the privileged? Is transformation a desirable goal for Africa, or a red herring to make us forget about the real work of decolonisation?

The Department of Public Law and the Free State Centre for Human Rights in the Faculty of Law at the University of the Free State invite you to a webinar on ‘Africa / Human rights / Transformation’ – a conversation with Johan Froneman, Dhaya Pillay, and Toyin Falola as part of Human Rights Week 2021.

The panel will discuss these and related issues from their perspectives as judges, academics, and politically aware Africans of different hues and origins. Prof Karin van Marle will be the moderator.

Date: 16 March 2021

Time: 15:00-16:30

Virtual event, details, and link to be provided upon RSVP to FSCHR@ufs.ac.za

Information on the speakers

Prof Toyin Falola is the Jacob and Frances Sanger Mossiker Chair in the Humanities at the University of Texas, Austin, and an extraordinary professor in the Free State Centre for Human Rights, University of the Free State.

Judge Dhaya Pillay is a judge of the High Court of South Africa (KwaZulu-Natal), Commissioner on the Independent Electoral Commission, and extraordinary professor in the Free State Centre for Human Rights, University of the Free State.

Judge Johan Froneman is a retired judge of the Constitutional Court of South Africa, and extraordinary professor in the Department of Public Law at the University of the Free State.

Prof Karin van Marle is professor of Jurisprudence at the University of the Free State.

News Archive

New research informs improved treatment of brain inflammation

2017-10-13

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish

Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology.

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs.

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept